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i g h l i g h t s
Acute overexposure to the metalloid selenium (Se) is neurotoxic in the human.
Neurotoxicity of chronic Se overexposure needs to be better characterized.
Chronic Se overexposure might induce lethargy and amyotrophic lateral sclerosis.
The different Se chemical species strongly vary in their neurotoxic effects.
Peripheral biomarkers of Se exposure may not reﬂect Se central nervous system levels.
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a b s t r a c t
Selenium is a metalloid of considerable interest in the human from both a toxicological and a nutri-
tional perspective, with a very narrow safe range of intake. Acute selenium intoxication is followed by
adverse effects on thenervous systemwith special clinical relevance,while theneurotoxicity of long-term
overexposure is less characterized and recognized. We aimed to address this issue from a public health
perspective, focusing on both laboratory studies and the few epidemiologic human studies available,ervous system diseases
myotrophic lateral sclerosis
pidemiologic studies
isk assessment
with emphasis on their methodological strengths and limitations. The frequently overlooked differences
in toxicity and biological activity of selenium compounds are also outlined. In addition to lethargy, dizzi-
ness, motor weakness and paresthesias, an excess risk of amyotrophic lateral sclerosis is the effect on the
nervous systemwhich has beenmore consistently associatedwith chronic low-level seleniumoverexpo-
sure, particularly to its inorganic compounds. Additional research efforts are needed to better elucidate
the neurotoxic effects exerted by selenium overexposure.
© 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved. This is an open-access article distributed under the terms of the Creative Com-
ons Attribution-NonCommercial-No Derivative Works License, which permits
on-commercial use, distribution, and reproduction in any medium, provided the
riginal author and source are credited.
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378-4274/$ – see front matter © 2013 The Authors. Published by Elsevier Ireland Ltd. Al
ttp://dx.doi.org/10.1016/j.toxlet.2013.11.0161. Introduction
The intense debate on the role of the metalloid selenium (Se) in
human health encompasses cancer etiology (Dennert et al., 2011;
Vinceti et al., 2013b), diabetes mellitus (Stranges et al., 2010;
Koyama et al., 2013), amyotrophic lateral sclerosis (ALS) (Vinceti
et al., 2012), and ‘Keshan’ cardiomyopathy (Lei et al., 2011; Li et al.,
2012), alongside other infectious and non-communicable diseases.
Se effects on human health may be both beneﬁcial (Rayman, 2000)
and detrimental (Vinceti et al., 2001), and the safe range of dietary
Se intake is still uncertain and controversial, as shown by the most
recent epidemiologic evidence and by the various standards issued
l rights reserved.
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y different agencies (Vinceti et al., 2009; Fairweather-Tait et al.,
011;Hurst et al., 2013; Vinceti et al., 2013a). Recent ﬁeld and labo-
atory studieshaveadded to this ambiguity, thus furtherhampering
he risk assessment of this metalloid and the deﬁnition of permit-
ed limits of environmental exposure, and preventing consensus on
ublic health policy (Vinceti et al., 2013a, 2013b).
Among the intriguing aspects are the role of Se in the etiol-
gy of neurological disease (Vinceti et al., 2001, 2009), also taking
nto account the complex peculiarities of Se physiopathology and
etabolism in the brain (Buckman et al., 1993; Pullen et al., 1995;
hanger, 2001; Bou-Resli et al., 2002; Schweizer et al., 2004;
charpf et al., 2007; Benner et al., 2013). Unfortunately, the relation
etween Se exposure andneurological diseases has been addressed
n few human studies, in some cases affected by relevant method-
logical limitations, and therefore it necessitates further validation
nd extension. A number of studies also suggested or evidenced the
ey importance of additional factors of interest when assessing Se
iological activity and toxicity, such as the chemical form of Se, and
he concurrent exposure to other toxic chemicals (i.e. mixed expo-
ures) (Gammelgaard et al., 2011; Michalke and Berthele, 2011;
wolak and Zaporowska, 2012; Solovyev et al., 2013; Vinceti et al.,
013c; Weekley and Harris, 2013).
In this review, we have brieﬂy analyzed Se neurotoxicity on the
asis of the scarce epidemiologic evidence available, also consid-
ring the biological plausibility of ﬁndings from laboratory and
eterinary medicine studies and the recent interest in Se neuro-
oxicity in risk assessments of metals and metalloids (Fresquez
t al., 2013). For the selection of the literature eligible for this
eview, we examined in detail PubMed-indexed papers using as
eSH search terms “Nervous System Diseases” associated with
selenium/toxicity”.Moreover,we systematically scanned PubMed
o retrieve the human and laboratory studies on Se investigating its
eurotoxicity. Some caveats need however to be outlined. First of
ll, a relation between Se and neurological disease calls into ques-
ion not only its toxicity but also its nutritional role. In fact, both
n increase and a decrease in the amount of bioavailable Se might
heoretically enhance the risk of neurological disease and its pro-
ression. The hypothesis that an increased Se intake may reduce
he risk of diseases such as Alzheimer’s disease or amyotrophic
ateral sclerosis (ALS), or counteract their clinical progression has
een evaluated in laboratory studies (Scharpf et al., 2007; Bellinger
t al., 2012; Raman et al., 2012), some of which indicated beneﬁ-
ial effects of organic and inorganic Se compounds in experimental
odels of neurodegenerative diseases (Schweizer et al., 2004; van
ersel et al., 2010; Wirth et al., 2010; Zhang et al., 2010; Caito
t al., 2011; Dasuri et al., 2013). However, no such effects have been
onﬁrmed by human investigations. Moreover, our review did not
nalyze the possible inverse relation between Se status and psy-
hiatric disorders, a currently controversial issue (Berr et al., 2012;
ao et al., 2012; Hurst et al., 2013; Miller et al., 2013).
. Laboratory studies on Se neurotoxicity
The neurotoxic effects of Se have long been investigated in
aboratory studies (Kasuya, 1976; Ammar and Couri, 1981; Rasekh
t al., 1997, 1998) and several recent studies on this issue have
een published (Xiao et al., 2006; Ayaz et al., 2008; Morgan et al.,
010; Souza et al., 2010; Maraldi et al., 2011; Estevez et al., 2012).
ne of the pioneering studies on Se neurotoxicity showed the
bility of both inorganic and organic Se compounds to induce
ehavioral and neurological manifestations in mice, with selenite
eing much more toxic than selenomethionine (Ammar and
ouri, 1981). In this investigation, Se species induced a decrease
n locomotion followed by ataxia and hind limbs paralysis and
ysfunction, generalized muscular ﬂaccidity and catalepsy-liketers 230 (2014) 295–303
state; respiratory and heart rates also markedly decreased, and
were followed by death due to respiratory and cardiac arrest.
The neurotoxic effects inducible by Se compounds include
among others an increase of central nervous system (CNS)
dopamine levels (Rasekh et al., 1997) and metabolites (Tsunoda
et al., 2000), alteration of cholinergic signaling and degeneration
of cholinergic neurons (Estevez et al., 2012), inhibition of glu-
tamate uptake (Nogueira et al., 2003; Ardais et al., 2010; Souza
et al., 2010) and prostaglandin D synthase (Islam et al., 1991;
Matsumura et al., 1991; Akarsu et al., 1998; Ardais et al., 2010),
decrease of total antioxidant status, gangliosides and sulphydryl
groups (Islam et al., 2004; Medeiros et al., 2012), of activity of
adenosine deaminase (Bitencourt et al., 2013), succinic dehydroge-
nase and acetylcholine esterase (Nehru and Iyer, 1994), and ﬁnally
increase of thiobarbituric acid reactive substances and lipid per-
oxidation (El-Demerdash, 2001; Islam et al., 2004; Glaser et al.,
2010; Medeiros et al., 2012). Additional Se-induced CNS alter-
ations are hypothermic and nociceptive responses as well as
CNS arousal (Mallory Boylan et al., 1990; Rasekh et al., 1998),
and reduction of locomotor activity (Rasekh et al., 1997, 1998;
Morgan et al., 2010). Finally, inorganic Se has also been shown
to induce apoptosis in cultured mouse cortical neurons even
at very low concentrations (Xiao et al., 2006). Some of these
effects are differentially exerted in various CNS regions, even with
opposite mechanisms (Zia and Islam, 2000; Islam et al., 2004;
Glaser et al., 2010; Medeiros et al., 2012). Se-induced neuro-
muscular blockade, tetanic spasm, alteration of nerve-ﬁber action
potentials and nerve membrane depolarization (Liu et al., 1989;
Lin-Shiau et al., 1990; Ayaz et al., 2008), and inhibition of human
squalene monooxygenase, which may in turn lead to peripheral
demyelinating neuropathy (Gupta and Porter, 2002), are all addi-
tional ﬁndings from experimental studies with potential clinical
implications.
The neurotoxicity of Se compounds is also manifested by its
ability to induce degeneration of motor neurons. In the study by
Maraldi et al. (2011), human neuroblastoma SKNBE cells were
shown to be more prone than other human cell lines to the neuro-
toxicity of inorganic and organic Se compounds: the lowest effects
on viability were observed at levels as low as 8g/l. Moreover, Se
induced a broad range of intracellular effects including increased
intracellular levels of reactive oxygen species, inducible nitric
oxide synthase and 3-nitrotyrosine, and superoxide dismutase-1
translocation from the cytosol to the mitochondria, the latter phe-
nomenon characterizing the neurodegerative process in the ALS
form associatedwith superoxide dismutase-1mutation. In another
study, inorganic tetravalent Se, selenite, induced degeneration of
cholinergic neurons and depletion of glutathione, impairing loco-
motor activity in Caenorhabditis elegansmodel (Morgan et al., 2010;
Estevez et al., 2012). The cholinergic motor neurons in the ventral
cords exhibited several neurodegenerative signs followingSeexpo-
sure: axonal beading, cellular swelling and nuclear cytoplasmatic
boundary loss and fragmentation. Se disrupted the orderly array
of presynaptic densities in this region, as previously observed at
the neuromuscular junction in a superoxide dismutase-1 mouse
model (Fischer et al., 2004). Moreover, veterinary research on
inorganic and organic Se poisoning in swine showed acute neuro-
muscular signs with progressive posterior paralysis and in some
cases forelimb involvement, progressing to lateral recumbence
and death (Harrison et al., 1983; Wilson et al., 1983; Anonymous,
2010; Nathues et al., 2010; Raber et al., 2010). These ﬁndings were
obtained both in observational studies following accidental acute
and chronic Se intoxication, and experimentally by administer-
ing Se-accumulator plants and various Se forms (Hartley et al.,
1984; Panter et al., 1996). Pathological ﬁndings were selective
degeneration of the ventral horns in the spinal cord, bilateral
poliomyelomalacia in the cervical and lumbar/sacral spinal cord
gy Let
i
t
o
1
i
e
t
o
B
i
t
(
l
o
k
g
o
o
o
H
2
b
2
n
4
a
t
r
e
o
c
e
o
h
(
n
s
(
p
C
i
a
p
w
e
a
l
3
a
d
o
t
e
P
v
u
s
o
aM. Vinceti et al. / Toxicolo
ntumescences, loss of neurons with reactive vascular prolifera-
ion and glial phagocytic cell response, alongside the degeneration
f brain stem motor nuclei (Harrison et al., 1983; Wilson et al.,
983). Such Se-induced neurotoxic effects have not been reported
n other animal species, with the exception of a study in cattle that
videnced a similar effect (Maag et al., 1960), thus corroborating
he observation in farm animals and wildlife of seleniferous areas
f the so-called ‘alkali disease’ and ‘blind staggers’ (Rosenfeld and
eath, 1964). The experimental studies in swine showed that the
norganic Se species selenite and selenate were more neurotoxic
han organic Se compounds at equivalent levels of Se exposure
Panter et al., 1996), regardless of the higher Se levels in tissues fol-
owing exposure to organic Se compounds. Remarkably, Se is the
nly element and more generally the only chemical, as far as we
now, which may be selectively toxic to the motor neurons, sug-
esting biological plausibility for its potential role in the etiology
f ALS, though such effect might strongly differ in different living
rganisms.
Overall, experimental studies have shown different toxic effects
f various inorganic and organic Se compounds (Borella et al., 1996;
oeﬁg et al., 2011; Nogueira and Rocha, 2011; Bitencourt et al.,
013; Boehler et al., 2013; Hazane-Puch et al., 2013), as suggested
y epidemiologic studies (Ashton et al., 2009; Vinceti et al., 2013a,
013b, 2013c). The neurotoxicity of inorganic Se may exceed the
eurotoxicity of organic Se (Ammar and Couri, 1981) by more than
0-fold. The differential toxicity andmetabolism of various organic
nd inorganic Se formsmakes it strongly improper to generalize the
erm ‘Se neurotoxicity’, whereas each neurotoxic effect should be
eferred to as a speciﬁc poisoning by a speciﬁc Se compound. An
xtensive effort should be made in the future to address the issue
f Se neurotoxicity in humans by assessing the speciﬁc effects of
ertain Se species.
An issue of interest is the ability of Se to counteract the toxic
ffects, mainly the neurotoxicity, of other elements. A large body
f evidence suggested an inhibitory effect exerted by Se against
eavy metal neurotoxicity, e.g. mercury (Wang et al., 2013), lead
Nehru and Iyer, 1994; Liu et al., 2013), cadmium, and aluminum
eurotoxicity. However, not all the results were consistent, and
ometimes Se served as an agonist in cases of mixed poisoning
Kasuya, 1976; Glaser et al., 2010). The ability of Se to form com-
lexes with other toxic elements in various organs including the
NS might also induce a longer persistence of the elements, which
s of some concern as it possibly leads to long-term release of Se
nd of heavy metals (Bjorkman et al., 1995) in the brain.
In conclusion, these above-mentioned experimental studies
oint to several and divergent mechanisms of Se neurotoxicity,
hich howevermay not necessarily be relevant to humans, consid-
ring species-related susceptibility and the differences between
cute, subacute or chronic exposures in laboratory studies and
ong-term low-level exposures in human lifetime.
. Relevance of Se speciation for CNS and exposure
ssessment methods
It is now clear that the impact of Se on the organism is strongly
ependent on its chemical species, as shown by a large number
f studies concerning the nutritional and toxicological proper-
ies of the metalloid in cell cultures and living organisms (Borella
t al., 1996; Michalke et al., 2009; Vinceti et al., 2009; Hazane-
uch et al., 2013; Weekley and Harris, 2013). The impact of the
arious Se species on neuronal health, however, is still largely
nknown and very controversial, since in contrast with toxicologic
tudies most molecular biological investigations using knock-
ut mice or cell culture experiments revealed neuroprotective
ction of Se compounds such as selenoprotein P-bound Se (SePP),ters 230 (2014) 295–303 297
glutathioneperoxidase-bound Se (GPx), and thioredoxinreductase-
boud Se (TrxR) (Wirth et al., 2010; Schweizer et al., 2011; Dasuri
et al., 2013). The studies suggested an important role of seleno-
proteins in the maintenance of optimal brain functions via redox
regulation, showing among other effects neuronal and axonal
degeneration after SePP depletion, the restoration of dopaminer-
gic neurotransmission by selenite, and mitigation of tau pathology
by selenate (Khan, 2010; van Eersel et al., 2010; Zhang et al., 2010;
Caito et al., 2011; Raman et al., 2012). Only a few Se species were
however investigated in these investigations, typically in an on/off
approach and rarely in a concentration-dependent manner.
This puzzled picture drawn from the literature about Se-caused
neuroprotection versus neurodegeneration triggered probably
(mainly) from elevated inorganic Se species, further highlights the
needs for Se speciation studies including species identiﬁcation and
quantiﬁcation when assessing Se neurotoxicity and more gener-
ally Se effects on CNS (Michalke et al., 2009; Solovyev et al., 2013;
Vinceti et al., 2013c). Moreover, such studies should advisably be
conducted in samples relevant to brain-Se metabolism, in order to
avoid inappropriate conclusions about the impact of Se on neu-
ronal health or disease without reference to its compound-speciﬁc
concentration in the CNS.
Terms related to chemical speciation have been published by
Templeton et al. (2000). In these guidelines, elemental speciation
is linked to a quality-controlled clear species identiﬁcation and
quantiﬁcation of all species of an element present in a represen-
tative sample. A literature survey on Se speciation in neuronal
relevant tissue or body ﬂuids revealed that today such papers are
scarce. Michalke and Berthele (2011) published a ﬁrst snapshot of
Se speciation in human cerebrospinal ﬂuid (CSF) after a preced-
ing study of this group had demonstrated the independence of
CSF-Se from serum-Se, hence pointing to a strict Se-species regula-
tion in the brain and/or regulated transport across neural barriers
(Dasuri et al., 2013). Six Se species were quantiﬁed of which SePP,
TrxR, human serum albumin-bound Se and selenate could be iden-
tiﬁed,while twomore Se-peaks remainedunidentiﬁed. A follow-up
study investigated paired serum/CSF samples to enlighten the pos-
sible transport of Se-species across neural barriers (Solovyev et al.,
2013). Se-species were quantiﬁed in both sample types (as g/l
for serum # CSF) as selenoprotein P (5.19 # 0.47), Se-methionine
(0.23#<LoD), GPx (4.2#0.036), TrxR (1.64#0.035), selenite (12.25
# 0.046) and human serum albumin-bound Se (18.03 # 0.068).
In comparison to other papers on Se species in serum or plasma
(Zhang et al., 2010) in that reference serum SePP was found at
somewhat lower level, while GPx was at similar concentration.
However, the results from paired samples demonstrated strong
differences not only between total Se concentrations and serum,
but more importantly between individual Se-species concentra-
tions from CSF and serum. Strikingly, strong correlations between
the two paired sample types were found only for GPx (r2 = 0.6636)
and TrxR (r2 =0.8031), resulting in calculated Q-values (conc-CSF
vs. conc-serum) of 8.3×10−3 for GPx or 21.3×10−3 for TrxR. Both
valueswere considerably increased compared to the albumin value
of 5.25×10−3 being in the normal range for healthy neural barriers
of this age group. This increase of Q-values was explained by their
facilitateddiffusionor transport acrossneuralbarriersor their inde-
pendent expression in the brain. Interestingly, no correlation was
found between serum and CSF content of the inorganic Se species
selenite and selenate, of the organic form SePP, and of overall Se
(Solovyev et al., 2013; Vinceti et al., 2013c), indicating the inabil-
ity of peripheral indicators such as blood (or nails, urine and hair)
to assess Se exposure in speciﬁc compartments such as the CNS.
This may indicate the inadequacy of commonly used biomarkers
to assess Se exposure, and the potential role of individual factors
related to Se metabolism, possibly under genetic control, in deter-
mining Se CNS content.
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. Human studies: acute Se intoxication
Reports about acute Se intoxication include suicide attempts,
onsumption of Se-containing dietary supplements, intake of food
ources with very high Se content like Brazil nuts, occupational
xposures and rarer etiologies (Vinceti et al., 2001; Nuttall, 2006;
orris andCrane, 2013). In one of theﬁrst studies on acute Se expo-
ure, 5 workers out of 25 were noted as affected by progressive
izziness and severe lassitude after adding Se to the inkwhich they
sed (Buchan, 1947). In another report, a 22 year old female biol-
gy student died after the suicidal ingestion of a sodium selenate
olution (Lech, 2002): post-mortem examination showed cerebral
dema. Localized or generalized tremor (Ransone et al., 1961; Sioris
t al., 1980) and convulsions (Carter, 1966; Civil and McDonald,
978) were also shown to be prominent symptoms of acute Se
ntoxication.
A high occurrence of fatigue, irritability, and peripheral neu-
opathy followed the ingestion of over-the-counter tablets (in
he US) that contained 27,300g of Se, 182-fold higher than
abeled (Helzlsouer et al., 1985). Fatigue and paresthesiaswere also
eported following the consumption of a misformulated Se supple-
ent, hypothesized to contain high amount of organic Se (Clark
t al., 1996).
A recent detailed study on acute Se intoxication enrolled 97 sub-
ects accidentally exposed to misformulated dietary supplements
ontaining over 40,000g of Se as selenate, 200-fold the intended
ose (Morris and Crane, 2013), a preparation which caused the
everest Se toxicity outbreak ever occurred in the US, involving
01 cases (MacFarquhar et al., 2010). Thebiomarkers of acute expo-
ure to this inorganic hexavalent Se species were monitored, along
ith the long-termhealth effects of this exposure during a 2.5 year-
ollow-up in 73 subjects (Morris and Crane, 2013). Toenail Se levels
ere ﬁrst determined 4 months after consuming misformulated
e supplements, showing much higher values than the restored-
aseline concentrations, and also strongly correlated with total
e intake during the exposure period. Analyses performed serially
n subjects’ toenail specimens showed an increase of Se content
ver time, with a peak median lapsed time of 237 days after the
ast exposure and a median time to restored-baseline concentra-
ions of 411 days. The overall Se consumption by subjects ranged
etween 669,570 and 965,520g in 30 days, a dose exceeding
ore than 400 times the recommended dietary allowance in the
S (55–70g/day). Questionnaire data indicated a high occurrence
f dermatological lesions that usually follow Se overexposure, and
bout half asmany of the subjectsmanifested long-termneuropsy-
hological signs and symptoms: fatigue, confusion, memory loss,
nxiety, ﬁngertip tingling, depression, anger, irritability, insomnia,
izziness and imbalance, eye and vision problems and headache.
remors also occurred but in a lower number of subjects (20%
pproximately). The occurrence of ataxia was not investigated in
his study, but this sign had been observed in 13% of 201 patients
xposed to such Se-containingmisformulated supplement in a pre-
ious report (MacFarquhar et al., 2010). The natural history of this
cute Se toxicity is peculiar: inmost cases (57.1%), an improvement
f symptoms was reported after 2.5 years, whereas 33.3% of the
tudy group reported no improvement and 9.5% reported worsen-
ng, thus contradictingprevious reports on shorter recoveryperiods
Morris and Crane, 2013). This different natural history might be
scribed speciﬁcally to the ability of selenate to induce persis-
ent neurotoxic sequelae after acute intoxication. Some limitations
f this study must also be highlighted and were acknowledged
y the authors. The investigation was undertaken in response to
Se toxicity outbreak, had limited statistical power, and lacked
control group. There was no independent validation of health
ymptoms that had been self-reported: however, the exceed-
ngly high prevalence of symptoms supports their authenticity.ters 230 (2014) 295–303
Moreover, in the 27 study subjects for whom both peak toenail Se
concentrations and self-reported symptoms were available, some
evidence of a direct correlation, though statistically imprecise,
emerged (r=0.256; p=0.2 – courtesy of John Steven Morris, Uni-
versity of Missouri, unpublished data). A longer-term follow-up of
this population would be of considerable interest to assess the risk
of chronic diseases, including the neurological ones.
In summary, neurotoxicity in humans is highly prevalent, long
lasting and probably irreversible after acute Se poisoning, par-
ticularly for some Se species. However, most studies have not
systematically analyzed the neurological effects, and in some stud-
ies no such effects were noted. Therefore, the relations between
acute Se poisoning and neurological diseases, as well as the pos-
sible effects of chronic poisoning by low-level exposures, require
further epidemiologic investigation, as is needed for the differ-
ential neurotoxic effects of various Se compounds. An additional
issue is the possibility to identify common underlying toxicologi-
cal mechanisms of Se acute adverse effects on the nervous, dermal
and endocrine systems.
5. Human studies: chronic exposures to environmental Se
Neurotoxicity following chronic Se overexposure, considerably
more common than acute exposure, has been investigated by
very few epidemiologic studies, signiﬁcantly differing from each
other by their design and population characteristics, and the over-
all picture emerging from these investigations is incomplete and
not entirely consistent. Unfortunately, most studies carried out in
populations overexposed to environmental Se have not investi-
gated long-term neurological effects.
One of the ﬁrst and pioneering studies on the health effects of
chronic Se overexposure was carried out in China and speciﬁcally
in Hubei Province, characterized by a very high soil Se content par-
ticularly in its Enshi district (Yang et al., 1983; Zheng et al., 1992).
The local residents consumed locally-grown food, and largely used
locally-produced coal. Unusual signs and symptoms of Se poison-
ing were observed in this population (Yang et al., 1983; Zheng
et al., 1992; Yang and Zhou, 1994; Li et al., 2012). Neurologi-
cal signs were found in 18 out of 22 rural residents affected by
severe selenosis: the clinical picture included acroparesthesia and
dysesthesia (“pins and needles”), hyperreﬂexia, convulsions,motor
weakness and hemiplegia, abnormalities which were ascribed to
‘polyneuritis’ caused by Se intoxication. However, this diagnosis
does not appear to be adequate to explain all symptoms detected,
such as hyperreﬂexia and convulsions, which are at least in part
due to CNS involvement. Moreover, there was unfortunately no
direct information on the chemical forms of Se implicated in the
excess environmental exposure investigated in this study, though
the main source of exposure was diet, which is expected to contain
almost entirely organic Se. However, emissions from coal combus-
tion and consumption of contaminated drinking water may have
contributed to the Se exposure in that area, providing inorganic Se
in such case (Finkelman et al., 1999; Guijian et al., 2007; Vinceti
et al., 2013a).
During a subsequent survey carried out in the Enshi district by
the geologist Fiona Fordyce of the British Geological Survey, clinical
data on Se poisoning among rural residentsmade available by local
public health ofﬁcials were collected and reported, in addition to a
large body of environmental data about the features of Se contam-
ination (Fordyce, 1996, 2007). A variety of neurological signs and
symptoms deﬁned as ‘no strength in limbs’, ‘tingling limbs’ and
‘paralysis’ were found in a variable range of 1–5% among 180 sub-
jects from villages in which Se toxicity occurred (Fordyce, 1996).
However, relevant methodological details were not reported, such
as the sampling methodology, the extent of Se exposure in affected
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ndividuals, the Se species responsible of such intoxication, and the
xact rates of neurological signs and symptoms among the indi-
iduals investigated. Moreover, potential confounding from age,
ender, behavioral and environmental factors was not assessed,
nd no control group was provided. Despite these limitations, the
tudy provided evidence supporting a relation between chronic Se
verexposure and neurotoxic effects.
In a study carried out in the United States by Valentine et al.,
ealth status was assessed among 50 residents in three communi-
ies with unusually high Se content (mean=494, 194 and 327g/l)
n their tapwater (Valentine et al., 1987; Valentine, 1997). The con-
rol group included 99 residents in two communities with drinking
ater containing 2–3gSe/l. The exact nature of Se compounds
as not reported, but it seems reasonable to assume that Se was
norganic, probably selenate (Hu et al., 2009; Kuisi and Abdel-
attah, 2010). Blood and hair Se levels were moderately elevated,
nd urinary Se was considerably elevated in the highly exposed
esidents. The prevalence of neurological diseases (“diseases of the
erves, paralysis or numbness”), examined only in the age group
8–55and forparticipantswhowereusersof tapwater,was limited
ut it tended to behigher in the exposed group (3/50, 6%) compared
ith the reference group (1/99, 0.5%), and this was also true when
ubjects with higher Se status (deﬁned as urine Se>70g/day or
lood Se>120g/l) were investigated and compared with resi-
ents with the lower exposure (5.4% vs. 1.7% using urine Se as
n indicator, 4.9% vs. 1.8% using blood Se) (Valentine et al., 1987).
broad spectrum of neurological symptoms (depression, dizzi-
ess, musculoskeletal pain and headache) was more frequent in
esidents in the exposed communities compared with unexposed
opulations, and this was conﬁrmed in the subgroup with higher
e exposure according to biomarkers. However, the evaluation of
hese comparisons was difﬁcult due to the small sample size of the
roups investigated.
The risk of neurological symptoms was estimated in 142 inha-
itants of areas with endemic Se overexposure from South Dakota
nd Wyoming (Longnecker et al., 1991), having a median Se daily
ntake of around 200g. No effect of Se exposure on the risk of
aresthesias was found (it actually decreased). By contrast, an
ncreased risk of lethargy emerged since the odds ratio (OR) of
aving this sign more frequently than the median for an increase
f one standard deviation of whole blood, toenails, or dietary Se
as equal to 1.41 (95% conﬁdence interval (CI) 1.01–1.96), 1.41
1.02–1.95), and 1.43 (0.98–2.09), respectively, and a slight excess
isk of muscle twitches (OR: 1.17 (0.84–1.64), 1.10 (0.80–1.51),
nd 1.28 (0.87–1.88)) and dizziness (OR: 1.20 (0.88–1.64), 1.29
0.94–1.76), and 1.17 (0.82–1.66)) was also noted. The authors also
tated that the ‘statistical signiﬁcance’ of the association between
e exposure and lethargy decreased after excluding one inﬂuential
bservation from the analysis, or adjusting for rancher-nonrancher
tatus, but they did not report in detail the relevant ORs with their
5% CIs.
A unique situation of chronic exposure (1974–1988) to drinking
ater with a high content (around 8g/l) of selenate of geologic
rigin was studied in the Rivalta neighborhood in Reggio Emilia,
taly. Drinking water in the rest of municipal neighborhoods con-
ained Se levels far below 1g/l, as usual in underground water
n Italy and elsewhere (Vinceti et al., 1998, 2000, 2010). After ﬁx-
ng the local problem of such high Se level too close to the upper
tandard of 10g/l (Vinceti et al., 2013a), Se water levels in Rivalta
ecreased to less than 1g/l. The analysis of educational attain-
ent level and occupation in the cohorts consuming the high- and
ow-Se tapwater showed a comparable proﬁle (Vinceti et al., 1995),
n observation that along with the very similar chemical compo-
ition of their tap waters apart from Se made it possible to deﬁne
he study setting as a natural experiment, usually of strong interest
n environmental epidemiology (Rothman et al., 2008). This settingters 230 (2014) 295–303 299
thus allowed to investigate a potentially toxic exposure, inorganic
Se (nearly absent in foodstuffs (Combs, 2001)), also minimizing
the risk of bias from confounding. The occurrence of neurologi-
cal diseases was investigated in the cohorts of Rivalta residents,
using mortality and, where possible, incidence, as end-points of
interest during 9–12 years of follow-up. Two neurodegenerative
disorders, Parkinson’s disease and ALS, showed an excessmortality
(Vinceti et al., 1995, 2000) based on three deaths for each disease:
the inclusion of these two diseases was ﬁrst done non-speciﬁcally,
considering only the causes of death for which an increased mor-
tality emerged. Further validation of ALS risk was done through
two incidence studies (Vinceti et al., 1996, 2010), whose design
and implementation was prompted not only by the original results
of the Rivalta mortality studies but also by the original descrip-
tion of a cluster of the disease associated with excess Se exposure
in the US. Such investigation was the report of a cluster of ALS,
including four cases of the disease, in a seleniferous region of
South Dakota (Kilness and Hochberg, 1977). Additional evidence
supporting the Se-ALS association was provided by laboratory and
veterinary medicine studies which showed a selective motor neu-
ron toxicity of some Se compounds in swine (Vinceti et al., 2012,
2013c). The indication of an excess risk for ALS (and Parkinson’s
disease) from the Rivalta studies suggested therefore a major con-
cern, to be further evaluated in populations exposed to high levels
of inorganic Se (Vinceti et al., 2013a).Despite the lowstatistical pre-
cision of the estimates due to the small numbers of observed cases,
this study also contributed to the suggestion of a precautionary re-
assessment of the current safe upper limit of Se level in drinking
water (Vinceti et al., 2013a). Interestingly, early-onset alopecia has
been recently associated to a higher risk of subsequent onset of
ALS (Fondell et al., 2013), an observation is of interest since alope-
cia is a typical effect of Se overexposure even at low doses (Vinceti
et al., 2001; Nuttall, 2006; Lippman et al., 2009), although alopecia
clearly hasmanypossible causes including a single nucleotidepoly-
morphism variant in the region of gene TAR DNA-binding protein
43, also suggested to be implicated in ALS pathogenesis (Fondell
et al., 2013)
A study on 448 residents aged 15–87 years in 12 communities
in the Brazilian Amazon tested the hypothesis that Se exposure,
as assessed through several biomarkers of exposure, could affect
motor functions (Lemire et al., 2011). High-level exposure to Se and
mercury (Hg) in these populations derived from the consumption
of a Se-rich diet of Brazil nuts, ﬁsh species, meat and eggs (Lemire
et al., 2012), and themedian plasma Se level resulted to be 135g/l.
The study results showed a direct association between Se plasma
levels and motor performance, while simultaneously controlling
Hg and lead (Pb) blood levels. These results appear to disprove
the detrimental effect of Se exposure on motor functions, but may
also be due to confounding, such as unmeasured heavy metals
(other than Hg and Pb) and other chemicals. Moreover, the study
did not address exposure to speciﬁc Se compounds, although they
were most likely organic because of their dietary origin. Finally,
the results may be irrelevant to ALS, a rapidly progressive and
extremely severe disease which cannot be directly compared to
mild to moderate declines in motor functions.
The peculiar sensitivity of children to adverse neurotoxic effects
of Se was addressed in 102 Canadian Inuit children aged 5–6 years.
Umbilical cord levels of several contaminants were measured at
their birth. The high consumption of ﬁsh and marine mammals
by this population was associated to an unusually high intake of
polychlorinated biphenyls, methyl-Hg, Se and other potentially
neurotoxic substances (Saint-Amour et al., 2006), with Se umbil-
ical blood level being 429g/l on the average. Measurements of
pattern-reversal visual evoked potentials (VEP) N75, P100 and
N150 were conducted to assess developmental neurotoxicity. VEP
exhibited longer latencies, suggesting optic nerve demyelination
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s a consequence of elevated Se blood levels on the visual system,
ven after adjusting for potential confounders such as methylmer-
ury inmultivariate analysis. Thus, high Se intake during childhood
ight have a negative impact on the visual system and not be pro-
ective against methylmercury toxicity, suggesting the occurrence
f subclinical effects at high Se blood levels. Clearly, these effects at
oung agemay be different fromwhat can be observed at older age,
nd the possibility of confounding or effect modiﬁcation by other
ontaminants should also be considered (Saint-Amour et al., 2006;
ang et al., 2013).
Another study performed neurobehavioral assessment in a
ohort of 927 3-day old Chinese neonates using a Neonatal Behav-
oral Neurological Assessment score for functional abilities based
n 6 indexes: behavior, passive tone, active tone, primary reﬂexes
nd general assessment (Yang et al., 2013). Both a direct corre-
ation of the score with Se cord levels <100g/l and an inverse
ssociation for higher Se levels were found, suggesting the occur-
ence of an inverse U-shaped relation between this behavioral and
eurological assessment and Se exposure. These results indicate
n extremely narrow margins of safety of Se exposure in neonates,
ossibly suggesting higher susceptibility to Se neurotoxicity in the
arly developmental period (Yang et al., 2013).
Otherenvironmental Seoverexposureshavebeendescribed, but
eurological issuesdonotunfortunately appear tohavebeen inves-
igated in the seleniferous areas spread throughout the world such
s in Venezuela, Mexico, and India (Brätter et al., 1991; Brätter
nd Negretti de Brätter, 1996; Vinceti et al., 2001; Hira et al.,
004; Hurtado-Jimenez and Gardea-Torresdey, 2007; Dhillon and
hillon, 2009).
The investigation of chronic occupational exposures is another
otential approach to assess health effects of chronic Se expo-
ure, but such exposures in workers appear to be uncommon, and
oreover neurotoxicity following long-term Se exposure in occu-
ational settings has been rarely investigated. Such analyses of
ealth effects of Se exposure in occupational settings may also
e of considerable interest since it may involve ‘rare’ exposure to
norganic volatile Se compounds, speciﬁcally released in such envi-
onments.We are aware of two investigationswhich evaluated the
onsequence of chronic exposure. Holness et al. (1989) assessed
ealth status in 40 Se-exposed copper reﬁnery workers and 150
ontrols: a few neurological symptoms were more prevalent in the
xposed individuals, including dizziness, sleep disturbances and
articularly paresthesias. The latter symptomwas reported by 29%,
5% and 45% of the 31, 23 and 29 Se-exposed workers examined
n three consecutive visits, respectively, compared with a rate of
% in a control group including 150 individuals. Stiffness, fatigue
nd muscle-joint pain were also found as strongly increased in the
e-exposed workers. In another occupational study, weakness and
atiguewere found tobe considerablymoreprevalent in19workers
ho were exposed to Se during the manufacture and maintenance
ork of drums used in photocopy machines, compared with a con-
rol group of 15 unexposed workers (Srivastava et al., 1997).
An alternative approach to assess the risk of neurological dis-
ases associated with Se exposure has been the implementation of
ase–control and cross-sectional studies based on biomarkers. Se
lood and tissue levels in neurological patients and controls were
easured in several studies, even though some of them were of
imited size and did not control for potential confounding factors.
hese studies addressed Alzheimer’s disease (Ceballos-Picot et al.,
996; Loef et al., 2011), Parkinson’s disease (Qureshi et al., 2006;
ounes-Mhenni et al., 2013) and ALS (Mitchell et al., 1991; Ince
t al., 1994; Markesbery et al., 1995; Vinceti et al., 1997; Bergomi
t al., 2002; Vinceti et al., 2013c).Majormethodological limitations,
owever, affected these investigations. First, exposure assessment
f Se was based on indicators such as toenails or blood Se levels,
hich may be unreliable in assessing Se burden in the CNS andters 230 (2014) 295–303
possibly other target organs (Solovyev et al., 2013; Vinceti et al.,
2013c). Moreover, these studies investigated the overall Se con-
tent in biological ﬂuids, disregarding the speciﬁc exposures to the
different Se compounds and the complex patterns which may arise
from Se speciation studies. For example, in a recent investigation in
newly diagnosed ALS patients (thus minimizing a disease-induced
effect on Se biomarkers) and matched hospital controls, in which
the CSF content of the various Se compounds was measured, levels
of organic Se species were lower but concentrations of selenite and
human serumalbumin-bound Se levelswere higher in ALS patients
(Vinceti et al., 2013c). In general, most of the case–control and
cross-sectional studies assessing overall Se exposure in patients
with neurological diseases suffered from severe risk of biases such
as selection bias, inadequate exposure assessment, confounding,
and reverse causality. To yield reliable information of etiologic
importance, studies using organ-speciﬁc indicators of exposure to
single Se compounds should be carried out, though the complexity
of such studies limits their feasibility.
6. Moving forward: research priorities and precautionary
risk assessment for Se neurotoxicity
Current epidemiologic evidence in the human unambiguously
shows the neurotoxicity of acute Se exposure and also appears to
support such effects following low-level chronic Se overexposure,
although the latter relation is still inadequately characterized. The
biological plausibility of Se neurotoxicity is also clearly supported
by laboratory and veterinary medicine evidence. The results of
the few human studies conducted on this issue as well as their
limitations, as described above, call for further investigation of
Se neurotoxicity, focusing on the effects of long-term low-level
Se overexposure as well as the speciﬁc activity of the various Se
species. Additional evidence regarding these issues is needed also
to better assess the safe range of Se exposure, which is still contro-
versial.
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